Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 110,734 | 121,169 | 129,063 | 60,536 | 68,657 |
| Receivables | 6,867 | 17,763 | 11,801 | 11,864 | 10,444 |
| Inventories | 8,066 | 6,169 | 7,884 | 8,125 | 7,198 |
| TOTAL | $130,183 | $149,269 | $151,673 | $81,721 | $89,169 |
| Non-Current Assets | |||||
| PPE Net | 3,839 | 3,893 | 3,918 | 3,858 | 3,801 |
| Other Non-Current Assets | 7,103 | 7,263 | 7,968 | 8,119 | 9,264 |
| TOTAL | $10,942 | $11,156 | $11,886 | $11,977 | $13,065 |
| Total Assets | $141,125 | $160,425 | $163,559 | $93,698 | $102,234 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 25,550 | 39,856 | 17,192 | 15,128 | 12,307 |
| Accrued Expenses | 3,449 | 5,029 | 5,128 | 5,001 | 3,314 |
| Other current liabilities | 1,000 | 1,000 | 1,561 | 1,364 | 1,089 |
| TOTAL | $31,753 | $47,608 | $25,574 | $23,155 | $18,298 |
| Non-Current Liabilities | |||||
| Long Term Debt | 25,099 | 27,519 | 29,940 | 31,843 | 33,746 |
| Deferred Revenues | 1,092 | 1,092 | 1,092 | 1,092 | 1,048 |
| Other Non-Current Liabilities | 99,209 | 99,570 | 92,491 | 91,355 | 91,376 |
| TOTAL | $143,426 | $146,479 | $142,094 | $143,133 | $144,866 |
| Total Liabilities | $175,179 | $194,087 | $167,668 | $166,288 | $163,164 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 125,450 | 122,045 | 122,003 | 99,724 | 99,328 |
| Common Shares | 124 | 122 | 121 | 99 | 99 |
| Retained earnings | -455,055 | -446,998 | -415,138 | -399,692 | -386,144 |
| TOTAL | $-34,054 | $-33,662 | $-4,109 | $-72,590 | $-60,930 |
| Total Liabilities And Equity | $141,125 | $160,425 | $163,559 | $93,698 | $102,234 |